Which drug has an intravenous dosing option of 2 mg/kg as part of its schedule?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $9.99Unlock all

Enhance your dermatological knowledge with the Dermatology Week 1 Exam. Engage with multiple choice questions that provide insights and detailed explanations to gear you up for testing success. Prepare effectively for your exam!

Multiple Choice

Which drug has an intravenous dosing option of 2 mg/kg as part of its schedule?

Explanation:
The key idea is that only one of these drugs offers an intravenous, weight-based dosing option. Golimumab has an IV formulation (Simponi Aria) given as 2 mg/kg at weeks 0 and 4, then every 8 weeks. The others are used by subcutaneous injections at fixed doses (certolizumab pegol, adalimumab, and etanercept), with no standard IV 2 mg/kg regimen. So the drug with an intravenous 2 mg/kg dosing schedule is golimumab.

The key idea is that only one of these drugs offers an intravenous, weight-based dosing option. Golimumab has an IV formulation (Simponi Aria) given as 2 mg/kg at weeks 0 and 4, then every 8 weeks. The others are used by subcutaneous injections at fixed doses (certolizumab pegol, adalimumab, and etanercept), with no standard IV 2 mg/kg regimen. So the drug with an intravenous 2 mg/kg dosing schedule is golimumab.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy